계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Clovis Oncology
company
About
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments.
- 251 - 500
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $145M
- Industries
- Biopharma
- Founded date
- Jan 1, 2009
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$145M
Clovis Oncology has raised a total of
$145M
in funding over 2 rounds. Their latest funding was raised on
May 21, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 21, 2009 | Series Unknown | $145M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Clovis Oncology is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
